PACLITAXEL FOR INJECTION
BIOLYSE PHARMA CORPORATION
Quick answers
Is there a shortage of PACLITAXEL FOR INJECTION in Canada?
No. There is no current shortage of PACLITAXEL FOR INJECTION 6MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
PACLITAXEL INJECTION USP
SANDOZ CANADA INCORPORATED
Other Products
ABRAXANE FOR INJECTABLE SUSPENSION
BRISTOL-MYERS SQUIBB CANADA
PACLITAXEL POWDER FOR INJECTABLE SUSPENSION NANOPARTICLE, ALBUMIN-BOUND PACLITAXEL
PANACEA BIOTEC PHARMA LIMITED
DIN
02244372
Strength
6MG
Dosage Form
Solution
Route
Intravenous
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from BIOLYSE PHARMA CORPORATION
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.